# Congenital Adrenal Hyperplasia in Children: The Relationship between Plasma Renin Activity and Hypertension

**Authors:** Siska Mayasari Lubis, Frida Soesanti, Eka Laksmi Hidayati, Bambang Tridjaja AAP

PMC · DOI: 10.30476/ijms.2023.98508.3058 · Iranian Journal of Medical Sciences · 2024-06-01

## TL;DR

Children with salt-wasting congenital adrenal hyperplasia and low plasma renin activity are more likely to develop hypertension.

## Contribution

This study identifies a link between low plasma renin activity and hypertension risk in salt-wasting CAH children.

## Key findings

- 50% of 21-OHD CAH patients had hypertension.
- Salt-wasting CAH patients had higher hypertension rates than simple virilizing types.
- Low PRA levels were associated with a 1.09 times higher risk of hypertension.

## Abstract

Children with Congenital Adrenal Hyperplasia (CAH) have a higher chance of hypertension. The likelihood of hypertension is higher in CAH children who get fludrocortisone medication and have an over-suppression. Plasma renin activity (PRA) is a sensitive indicator when the fludrocortisone dose is insufficient. The objective of this study is to assess the relationship between plasma renin activity with hypertension in 21-hydroxylase-deficient (21-OHD) CAH children.

This cross-sectional observational analytical study was conducted in 2019 at the Pediatric Endocrinology Outpatient Clinic in Dr. Cipto Mangunkusumo Hospital (RSCM), Jakarta, Indonesia. The subjects were 21-OHD CAH children, aged >6 months to 18 years who had already taken hydrocortisone with or without fludrocortisone for at least 6 months, and were divided into hypertension and non-hypertension groups. The subjects were selected by a consecutive sampling method.
Data was analyzed using SPSS software (version 23.0) with unpaired t test analysis and multiple logistic regression test. Statistical significance was achieved if P<0.05.

Forty 21-OHD CAH patients were included, and 20 subjects (50%) had hypertension. A higher incidence of hypertension was found in salt-wasting CAH than in simple virilizing types (59.3% vs 30.8%). There was a significant mean difference in PRA levels between hypertension and non-hypertension groups in salt-wasting patients (P=0.016). A significant difference between the last dose of hydrocortisone with the number of hypertension patients in salt-wasting patients (P=0.032) was found, and low PRA levels showed a 1.09 times higher risk of hypertension.

Children with salt-wasting CAH with low PRA levels had a higher risk of getting hypertension.

## Linked entities

- **Chemicals:** fludrocortisone (PubChem CID 31378), hydrocortisone (PubChem CID 5754)
- **Diseases:** Congenital Adrenal Hyperplasia (MONDO:0015898)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}
- **Diseases:** 21-OHD (MESH:C536209), Hypertension (MESH:D006973), salt-wasting (MESH:D013651), 21-hydroxylase-deficient (MESH:C535979), 21-OHD CAH (MESH:D000312)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11214679/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC11214679/full.md

---
Source: https://tomesphere.com/paper/PMC11214679